Observation and nursing of allergic rhinitis curative in treatment of standardized dust mites vaccine immune
-
摘要:
目的探讨过敏性鼻炎患者进行标准化尘螨变应原疫苗免疫治疗时，护理干预、强化心理护理和健康教育对免疫治疗进度及治疗效果的影响。 方法将86例过敏性鼻炎患者进行标准化尘螨变应原疫苗（安脱达）免疫治疗，治疗基础上实行护理干预、强化心理护理和健康教育，并对治疗疗效和症状改善评分, 全身不良事件分级。 结果86例患者全部完成2年的免疫治疗，无脱漏病例。治疗结束时显效38例（44.2%）、有效42例（48.8%）、无效6例（7%），总有效率为93%。 结论安脱达免疫治疗过敏性鼻炎疗效是安全、有效、可靠的，高质量的护理干预是确保治疗效果的关键。 Abstract:Objective To study the patients with allergic rhinitis to standardize dust mite allergen vaccine immune therapy,nursing intervention, strengthening psychological nursing and health education on the immune treatment progress andtreatment effect. Methods A total of 86 patients with allergic rhinitis were standardized dust mite allergen vaccine immunetherapy, treatment based on the implementation of nursing intervention, strengthening psychological nursing and healtheducation, and the curative effect and symptoms improved ratings, systemic adverse events. Results All the 86 patients wereperformed immunotherapy for 2 years, no cases missed. At the end of treatment, 38 cases (44.2%) were markedly effective, 42cases (48.8%) and 6 cases (7%) were ineffective. The total effective rate was 93%. Conclusion The effect of immune treatmentfor allergic rhinitis curative is safe, effective and reliable, high quality nursing intervention is the key to ensure the therapeuticeffect. -
表 1 全身不良反应分级方案
分级 表现 0 无症状或非特异性症状 轻度全身反应：症状：局部荨麻疹、鼻炎或轻度哮喘 Ⅰ （峰流速自基线下降≤20%） 重度全身反应,症状：发生缓慢的、泛发的荨麻疹和，或重度哮喘 Ⅱ （峰流速自基线下降<40%） 重度(非致命性)全身反应： Ⅲ 症状：快速发生的（<15 min）的泛发的荨麻疹、血管性水肿或严重哮喘 （峰流速自基线下降>40%） Ⅳ 变应性休克：症状：迅速发生的瘙痒、潮红、红斑、泛发性荨麻疹、喘鸣（血管性水肿）、 速发哮喘、低血压等 
下载: 导出CSV
-
[1] 孔维佳, 周 梁, 许 庚, 等. 耳鼻咽喉头颈外科学[M]. 北京: 人民卫生出版社, 2005: 75-80. [2] 韩德民. 变应性鼻炎临床诊疗手册[M]. 北京: 人民卫生出版社, 2007: 115-21. [3] 朱 丽, 马芙蓉, 王 丽, 等. 变应性鼻炎标准化变应原皮肤点刺试验[J]. 中国耳鼻咽喉头颈外科杂志, 2007, 14(6): 14-6. http://www.cnki.com.cn/Article/CJFDTOTAL-XDYF200804037.htm [4] Bousquet J, Lockey R, Mailing HJ. Allergen immunotherapy: thempeutic vaccines for allergic disease,A WHO position paper [J].J Allwegy Clin Immunol, 1998, 102(4): 558-62. doi: 10.1016/S0091-6749(98)70271-4 [5] 中华医学会耳鼻咽喉科学分会. 变应性鼻炎的诊治原则和推荐方案[J]. 中华耳鼻咽喉头颈外科杂志, 2005, 40(3): 166-7. http://www.cnki.com.cn/Article/CJFDTOTAL-XCYS200516012.htm [6] 中华医学会耳鼻咽喉学分会. 变应性鼻炎诊断标准及疗效评定标准(1997年修订,海口) [J]. 中华耳鼻喉科杂志, 1998, 33(3): 134-5. http://www.cnki.com.cn/Article/CJFDTOTAL-ZHEB803.003.htm [7] rez-Cuesta RE, Bousquet J, Canonica GW, et al. Standards forpractical allergen-specific immunotherapy[J]. Allergy, 2006, 61(Suppl82): 1-20. http://cn.bing.com/academic/profile?id=2128140264&encoded=0&v=paper_preview&mkt=zh-cn [8] Bousquet J, Lockey R, Mallingh J, et al. Auergen immunothempy: Thempeutic vaccines for a11ergic diseases.A WHO Position Paper[J]. Allergy Clin Immunol, 1998, 102(4 pt1): 558-62. http://cn.bing.com/academic/profile?id=2033232206&encoded=0&v=paper_preview&mkt=zh-cn [9] Bousquet J, Van Cauwenberge P, KhaltaevN, et al. Allergy rhinitis and its impact on asthma[J]. J Allergy ClinIImmunol, 2001, 108(5): 147-54. doi: 10.1067/mai.2001.118891 [10] Bousquet J, Lockey R, Mallingh J. Auergen immunothempy: Thempeutic vaccines for a11ergic diseases[J]. World Health Orgranization Position Paper Auergy, 1998, 53(Suppl 44): 1-29. http://cn.bing.com/academic/profile?id=2033232206&encoded=0&v=paper_preview&mkt=zh-cn [11] 黎景梅, 成丽兰. 阿罗格皮肤点刺试验和脱敏治疗在变应性鼻炎中的应用及护理[J]. 齐鲁护理杂志, 2006, 12(6): 1004-8. http://www.cnki.com.cn/Article/CJFDTOTAL-QLHL200611010.htm [12] 胡少芝, 邝景云, 赵群庆. 尘螨过敏患者治疗依从性分析与护理干预[J]. 护理学报, 2006, 13(6): 46-7. http://www.cnki.com.cn/Article/CJFDTOTAL-NFHL200606023.htm [13] 丁海明, 陈曲波, 潘婉仪, 等. 广州地区吸入过敏原引起过敏性鼻炎过敏原谱分析[J]. 广东医学, 2012, 33(14): 2157-8. http://www.cnki.com.cn/Article/CJFDTOTAL-GAYX201214055.htm [14] 杜书章, 汪晓凯, 刘萃红. 变应性鼻炎124例治疗体会[J]. 郑州大学学报(医学版), 2005, 40(2):369-70. http://www.cnki.com.cn/Article/CJFDTOTAL-HNYK20050201Y.htm [15] 刘 军. 脱敏治疗过敏性鼻炎的临床疗效及护理[J]. 中国医学装备, 2013, 10(5): 83-5. http://www.cnki.com.cn/Article/CJFDTOTAL-YXZB201305031.htm -
点击查看大图
表(1)
计量
- 文章访问数: 766
- HTML全文浏览量: 216
- PDF下载量: 2
- 被引次数: 0
